Baden, Megu Yamaguchi
,
Imagawa, Akihisa http://orcid.org/0000-0002-4213-3229
Abiru, Norio
Awata, Takuya
Ikegami, Hiroshi
Uchigata, Yasuko
Oikawa, Yoichi
Osawa, Haruhiko
Kajio, Hiroshi
Kawasaki, Eiji
Kawabata, Yumiko
Kozawa, Junji
Shimada, Akira
Takahashi, Kazuma
Tanaka, Shoichiro
Chujo, Daisuke
Fukui, Tomoyasu
Miura, Junnosuke
Yasuda, Kazuki
Yasuda, Hisafumi
Kobayashi, Tetsuro
Hanafusa, Toshiaki
Funding for this research was provided by:
Japan Diabetes Society
Article History
Received: 9 February 2018
Accepted: 24 June 2018
First Online: 3 July 2018
Compliance with ethical standards
:
: Akihisa Imagawa received scholarship donations from Ono Pharmaceutical Co., Ltd. and MSD and honoraria for lectures from Ono Pharmaceutical Co., Ltd. Norio Abiru received research grants from Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb. Hiroshi Ikegami received a scholarship grant from Ono Pharmaceutical Co., Ltd. Yumiko Kawabata received a scholarship grant from Ono Pharmaceutical Co., Ltd. Other authors declare that they have no conflicts of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (The Ethics Committees of the JDS, date of approval: 26 August 2016, approval number: 28-003-(2), Osaka University Hospital, date of approval: 27 April 2016, approval number: 15589, and Osaka Medical College, date of approval: 10 January 2017, approval number: 2098) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.